Turnitin
降AI改写
早检测系统
早降重系统
Turnitin-UK版
万方检测-期刊版
维普编辑部版
Grammarly检测
Paperpass检测
checkpass检测
PaperYY检测
Prostate Cancer Biomarkers: From diagnosis to prognosis and precision-guided therapeutics
M Adamaki, V Zoumpourlis - Pharmacology & therapeutics, 2021 - Elsevier
Prostate cancer (PCa) is one of the most commonly diagnosed malignancies and among the
leading causes of cancer-related death worldwide. It is a highly heterogeneous disease …
leading causes of cancer-related death worldwide. It is a highly heterogeneous disease …
[HTML][HTML] Biomarkers for prostate cancer: from diagnosis to treatment
JY Chen, PY Wang, MZ Liu, F Lyu, MW Ma, XY Ren… - Diagnostics, 2023 - mdpi.com
Prostate cancer (PCa) is a widespread malignancy with global significance, which
substantially affects cancer-related mortality. Its spectrum varies widely, from slow …
substantially affects cancer-related mortality. Its spectrum varies widely, from slow …
HALP score and albumin levels in men with prostate cancer and benign prostate hyperplasia
Aims To evaluate the diagnostic significance of the novel index combining preoperative
haemoglobin, albumin levels, lymphocyte and platelet counts (HALP) in prostate cancer …
haemoglobin, albumin levels, lymphocyte and platelet counts (HALP) in prostate cancer …
[HTML][HTML] New generation biomarkers for the detection of prostate cancer
Malignant growth is the most dangerous illness with the most elevated mortality rate. Early
identification of malignant growth can be fundamental in effective treatment. One of the most …
identification of malignant growth can be fundamental in effective treatment. One of the most …
Scavenging of labile heme by hemopexin is a key checkpoint in cancer growth and metastases
Hemopexin (Hx) is a scavenger of labile heme. Herein, we present data defining the role of
tumor stroma-expressed Hx in suppressing cancer progression. Labile heme and Hx levels …
tumor stroma-expressed Hx in suppressing cancer progression. Labile heme and Hx levels …
[HTML][HTML] PSA based biomarkers, imagistic techniques and combined tests for a better diagnostic of localized prostate cancer
Prostate cancer represents the most encountered urinary malignancy in males over 50 years
old, and the second most diagnosed after lung cancer globally. Digital rectal examination …
old, and the second most diagnosed after lung cancer globally. Digital rectal examination …
Prostate cancer screening using chemometric processing of GC–MS profiles obtained in the headspace above urine samples
V Deev, S Solovieva, E Andreev, V Protoshchak… - … of Chromatography B, 2020 - Elsevier
The development of screening methods for various types of cancer is of utmost importance
as the early diagnostics of these diseases significantly increases the chances for patient's …
as the early diagnostics of these diseases significantly increases the chances for patient's …
Advancements in Biomarkers of Prostate Cancer: A Review
P Agbetuyi-Tayo, M Gbadebo… - … in Cancer Research …, 2024 - journals.sagepub.com
Prostate cancer (PCa) is one of the most prevalent and deadly cancers among men,
particularly affecting men of African descent and contributing significantly to cancer-related …
particularly affecting men of African descent and contributing significantly to cancer-related …
Rational peptide design for targeting cancer cell invasion
Cell invasion is an important process in cancer progression and recurrence. Invasion and
implantation of cancer cells from their original place to other tissues, by disabling vital …
implantation of cancer cells from their original place to other tissues, by disabling vital …
[HTML][HTML] Key Considerations for a Prostate Cancer mRNA Vaccine
Prostate cancer has the second highest cancer mortality rate in the UK in males. Early
prostate cancer is typically asymptomatic, with diagnosis at a locally advanced or metastatic …
prostate cancer is typically asymptomatic, with diagnosis at a locally advanced or metastatic …